These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 4613460

  • 21. [Role of the liver in coagulation and fibrinolysis. Physiopathological and experimental aspects of the isolated liver].
    Losito R.
    Union Med Can; 1974 Dec; 103(12):2107-10. PubMed ID: 4466024
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of phenylbutazone on the distribution, elimination and anticoagulant action of dicumarol in rats.
    Jähnchen E, Wingard LB, Levy G.
    J Pharmacol Exp Ther; 1973 Oct; 187(1):176-84. PubMed ID: 4126886
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A comprehensive model for the humoral coagulation network in humans.
    Wajima T, Isbister GK, Duffull SB.
    Clin Pharmacol Ther; 2009 Sep; 86(3):290-8. PubMed ID: 19516255
    [Abstract] [Full Text] [Related]

  • 26. [Pharmacokinetics of 4-hydroxycoumarin derivative anticoagulants (a review of the literature)].
    Lakin KM, Krylov IuF, Kuperman AV, Grenaderov SIu.
    Farmakol Toksikol; 1981 Sep; 44(4):484-94. PubMed ID: 7026279
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. High usual dietary vitamin K intake is associated with low relative variability in vitamin K intake: implications for anticoagulant therapy.
    Presse N, Kergoat MJ, Ferland G.
    Br J Haematol; 2011 Apr; 153(1):129-30. PubMed ID: 21275964
    [No Abstract] [Full Text] [Related]

  • 29. Recent developments in understanding the mechanism of vitamin K and vitamin K-antagonist drug action and the consequences of vitamin K action in blood coagulation.
    Jackson CM, Suttie JW.
    Prog Hematol; 1977 Apr; 10():333-59. PubMed ID: 337364
    [No Abstract] [Full Text] [Related]

  • 30. [Influence of SKF 525A on the kinetics and action of an antivitamin K in the rat].
    Thonnart N, Letist D, Reuse J.
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):369-72. PubMed ID: 4848952
    [No Abstract] [Full Text] [Related]

  • 31. Current practice with vitamin K antagonist therapy.
    Kazmier FJ.
    Mayo Clin Proc; 1974 Dec; 49(12):918-22. PubMed ID: 4216730
    [No Abstract] [Full Text] [Related]

  • 32. Coumarin drug interactions.
    Kazmier FJ, Spittell JA.
    Mayo Clin Proc; 1970 Apr; 45(4):249-55. PubMed ID: 5439135
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D, Chambefort V, Decousus H.
    Rev Prat; 2001 Sep 01; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Pharmacokinetic aspects of overdosage and intoxication with oral anticoagulant drugs (author's transl)].
    Jähnchen E, Meinertz T.
    Arzneimittelforschung; 1977 Sep 01; 27(96):1849-56. PubMed ID: 303522
    [Abstract] [Full Text] [Related]

  • 37. Anticoagulant interactions.
    Br Med J; 1971 Oct 16; 4(5780):128-9. PubMed ID: 5113012
    [No Abstract] [Full Text] [Related]

  • 38. [Drug interactions in the use of cardiac glycosides].
    Wirth KE.
    Med Welt; 1981 Feb 13; 32(7):234-8. PubMed ID: 7010063
    [No Abstract] [Full Text] [Related]

  • 39. Control of clotting factor biosynthesis by vitamin K.
    Suttie JW.
    Fed Proc; 1969 Feb 13; 28(5):1696-701. PubMed ID: 4897771
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.